2020
DOI: 10.3171/2020.8.focus20611
|View full text |Cite
|
Sign up to set email alerts
|

Informed consent in neurosurgery: a systematic review

Abstract: OBJECTIVEInformed consent has served as a main principle of medical ethics and laws in the United States. The 1986 American Association of Neurological Surgeons Code of Ethics implied medicolegal liability for the failure to obtain informed consent without providing practical guidance regarding the application of informed consent to individual patient encounters in a medicolegal environment. Here, the authors aimed to identify baseline patient recall after discussions with neurosurgeons and their capacity to p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
37
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 46 publications
(37 citation statements)
references
References 31 publications
0
37
0
Order By: Relevance
“…Better models for empowering parents and obtaining informed consent in LMIC needs to be carefully addressed in future trials. Innovative approaches using infographics and videos to communicate different aspects of trial may improve participant understanding and reduce anxiety, 29 30 and such techniques may facilitate better informed consent in LMICs. Involving parents and family members in the design of studies would help in understanding their perspectives and addressing their priorities.…”
Section: Discussionmentioning
confidence: 99%
“…Better models for empowering parents and obtaining informed consent in LMIC needs to be carefully addressed in future trials. Innovative approaches using infographics and videos to communicate different aspects of trial may improve participant understanding and reduce anxiety, 29 30 and such techniques may facilitate better informed consent in LMICs. Involving parents and family members in the design of studies would help in understanding their perspectives and addressing their priorities.…”
Section: Discussionmentioning
confidence: 99%
“…Neurosurgery is amongst the medical specialties subject to the highest number of claims with an average payout of $440.000 [3]. In particular medical malpractice litigation in neurosurgery is associated with spinal procedures, as six out of the seven most claimed pathologies involved the spinal column [4,5]. In most cases, malpractice claims are motivated by three main factors: ascertaining the facts that led to a negative outcome in order to understand what happened, securing financial compensation and defining the alleged responsibility of the physician or the system.…”
Section: Discussionmentioning
confidence: 99%
“…In most cases, malpractice claims are motivated by three main factors: ascertaining the facts that led to a negative outcome in order to understand what happened, securing financial compensation and defining the alleged responsibility of the physician or the system. Curiously, even when poor outcome, poor performance or supposed negligence during procedure were supporting the claims, a bad physician-patient relationship represents the first risk factor of claims, no matter the outcome [4]. In a recent review about informed consent in neurosurgery, it emerged that the lack of informed consent is the basis for a large portion of malpractice.…”
Section: Discussionmentioning
confidence: 99%
“…This must be conducted longitudinally throughout the timeline of care in order to maintain informed consent. 110 Providers should also identify strategies to improve patient counseling.…”
Section: Third Tiermentioning
confidence: 99%
“…While these studies occur, novel NDs may be used under certain controlled conditions to promote informed consent. 110 First, clinicians must have reason to believe that the device will provide therapeutic benefit based on the pathology and function of the device. Second, only well-selected patients, namely those who have not benefited from medical therapy, traditional surgery, or current NDs or who do not qualify for such treatments, must be offered the novel ND, preferably within the context of a well-designed controlled trial with appropriate scientific and ethical guardrails.…”
Section: Future Neuromodulatory Devicesmentioning
confidence: 99%